BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 8140075)

  • 1. Erythromelalgic, thrombotic and haemorrhagic manifestations of thrombocythaemia.
    van Genderen PJ; Michiels JJ
    Presse Med; 1994 Jan; 23(2):73-7. PubMed ID: 8140075
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Erythromelalgic, thrombotic and hemorrhagic manifestations in 50 cases of thrombocythemia.
    Michiels JJ; van Genderen PJ; Lindemans J; van Vliet HH
    Leuk Lymphoma; 1996 Sep; 22 Suppl 1():47-56. PubMed ID: 8951772
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Platelet-mediated microvascular inflammation and thrombosis in thrombocythemia vera: a distinct aspirin-responsive arterial thrombophilia, which transforms into a bleeding diathesis at increasing platelet counts.
    Michiels JJ
    Pathol Biol (Paris); 2003 Apr; 51(3):167-75. PubMed ID: 12781799
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pathophysiology and treatment of platelet-mediated microvascular disturbances, major thrombosis and bleeding complications in essential thrombocythaemia and polycythaemia vera.
    Michiels JJ; Berneman ZN; Schroyens W; Van Vliet HH
    Platelets; 2004 Mar; 15(2):67-84. PubMed ID: 15154599
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Erythromelalgia and thrombocythemia: a disease of platelet prostaglandin metabolism--thesis, Rotterdam, 1981.
    Michiels JJ
    Semin Thromb Hemost; 1997; 23(4):335-8. PubMed ID: 9263349
    [No Abstract]   [Full Text] [Related]  

  • 6. Arterial thrombophilia in primary thrombocythemia. A case report.
    van Genderen PJ; Michiels JJ
    Angiology; 1994 Jun; 45(6):485-8. PubMed ID: 8203777
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aspirin-responsive painful red, blue, black toe, or finger syndrome in polycythemia vera associated with thrombocythemia.
    Michiels JJ; Berneman Z; Schroyens W; van Urk H
    Ann Hematol; 2003 Mar; 82(3):153-9. PubMed ID: 12634947
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Platelet-mediated erythromelalgic, cerebral, ocular and coronary microvascular ischemic and thrombotic manifestations in patients with essential thrombocythemia and polycythemia vera: a distinct aspirin-responsive and coumadin-resistant arterial thrombophilia.
    Michiels JJ; Berneman Z; Schroyens W; Koudstaal PJ; Lindemans J; Neumann HA; van Vliet HH
    Platelets; 2006 Dec; 17(8):528-44. PubMed ID: 17127481
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Uncontrolled thrombocytosis in chronic myeloproliferative disorders.
    Kessler CM; Klein HG; Havlik RJ
    Br J Haematol; 1982 Jan; 50(1):157-67. PubMed ID: 6976793
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Erythromelalgia--a thrombotic complication in chronic myeloproliferative disorders.
    Tarach JS; Nowicka-Tarach BM; Matuszek B; Nowakowski A
    Med Sci Monit; 2000; 6(1):204-8. PubMed ID: 11208311
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reduced platelet factor X-activating activity: a possible contribution to bleeding complications in polycythaemia vera and essential thrombocythaemia.
    Cortellazzo S; Colucci M; Barbui T; Dini E; Semeraro N
    Haemostasis; 1981; 10(1):37-50. PubMed ID: 7203175
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Erythromelalgia: a pathognomonic microvascular thrombotic complication in essential thrombocythemia and polycythemia vera.
    van Genderen PJ; Michiels JJ
    Semin Thromb Hemost; 1997; 23(4):357-63. PubMed ID: 9263352
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thrombocytosis and thrombocythemia.
    Mitus AJ; Schafer AI
    Hematol Oncol Clin North Am; 1990 Feb; 4(1):157-78. PubMed ID: 2155903
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanisms of bleeding and thrombosis in myeloproliferative disorders.
    Landolfi R; Marchioli R; Patrono C
    Thromb Haemost; 1997 Jul; 78(1):617-21. PubMed ID: 9198226
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Platelet consumption in thrombocythemia complicated by erythromelalgia: reversal by aspirin.
    van Genderen PJ; Michiels JJ; van Strik R; Lindemans J; van Vliet HH
    Thromb Haemost; 1995 Feb; 73(2):210-4. PubMed ID: 7792731
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Artefactual serum hyperkalaemia and hypercalcaemia in essential thrombocythaemia.
    Howard MR; Ashwell S; Bond LR; Holbrook I
    J Clin Pathol; 2000 Feb; 53(2):105-9. PubMed ID: 10767824
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Essential thrombocythemia: an uncommon cause of digital gangrene.
    Fernando EA; Senanayake B; Sivakumaran S
    Ceylon Med J; 1998 Mar; 43(1):34-5. PubMed ID: 9624842
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Essential thrombocythaemia and its neurological complications.
    Miller TD; Farquharson MH
    Pract Neurol; 2010 Aug; 10(4):195-201. PubMed ID: 20647525
    [TBL] [Abstract][Full Text] [Related]  

  • 19. No treatment for low-risk thrombocythaemia: results from a prospective study.
    Ruggeri M; Finazzi G; Tosetto A; Riva S; Rodeghiero F; Barbui T
    Br J Haematol; 1998 Dec; 103(3):772-7. PubMed ID: 9858229
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Maintenance therapy in the myeloproliferative disorders: the current options.
    Giles FJ
    Br J Haematol; 1991 Oct; 79 Suppl 1():92-5. PubMed ID: 1931719
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.